CN1107504C - 左布比卡因在儿科手术中的用途 - Google Patents

左布比卡因在儿科手术中的用途 Download PDF

Info

Publication number
CN1107504C
CN1107504C CN98802993A CN98802993A CN1107504C CN 1107504 C CN1107504 C CN 1107504C CN 98802993 A CN98802993 A CN 98802993A CN 98802993 A CN98802993 A CN 98802993A CN 1107504 C CN1107504 C CN 1107504C
Authority
CN
China
Prior art keywords
chirocaine
bupivacaine
levobupivacaine
dosage
hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN98802993A
Other languages
English (en)
Chinese (zh)
Other versions
CN1249683A (zh
Inventor
B·A·金纳利
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Darwin Discovery Ltd
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Publication of CN1249683A publication Critical patent/CN1249683A/zh
Application granted granted Critical
Publication of CN1107504C publication Critical patent/CN1107504C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
CN98802993A 1997-03-03 1998-03-03 左布比卡因在儿科手术中的用途 Expired - Lifetime CN1107504C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9704351.7 1997-03-03
GBGB9704351.7A GB9704351D0 (en) 1997-03-03 1997-03-03 Levobupivacaine and its use

Publications (2)

Publication Number Publication Date
CN1249683A CN1249683A (zh) 2000-04-05
CN1107504C true CN1107504C (zh) 2003-05-07

Family

ID=10808602

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98802993A Expired - Lifetime CN1107504C (zh) 1997-03-03 1998-03-03 左布比卡因在儿科手术中的用途

Country Status (20)

Country Link
US (1) US5910502A (enExample)
EP (1) EP0981348B1 (enExample)
JP (1) JP2001513814A (enExample)
KR (1) KR100535554B1 (enExample)
CN (1) CN1107504C (enExample)
AT (1) ATE240731T1 (enExample)
AU (1) AU719483B2 (enExample)
BR (1) BR9808302A (enExample)
CA (1) CA2279498C (enExample)
DE (1) DE69814852T2 (enExample)
DK (1) DK0981348T3 (enExample)
ES (1) ES2199424T3 (enExample)
GB (1) GB9704351D0 (enExample)
HU (1) HU224227B1 (enExample)
IL (1) IL131086A0 (enExample)
NO (1) NO324215B1 (enExample)
PL (1) PL190896B1 (enExample)
PT (1) PT981348E (enExample)
WO (1) WO1998038999A1 (enExample)
ZA (1) ZA981780B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1030652B1 (en) 1997-11-14 2012-04-25 Pacira Pharmaceuticals, Inc. Production of multivesicular liposomes
IL140899A0 (en) 1998-07-17 2002-02-10 Skyepharma Inc Lipid/polymer containing pharmaceutical compositions and processes for the preparation thereof
IL158819A0 (en) * 2001-05-31 2004-05-12 Skyepharma Inc Encapsulation of nanosuspensions in liposomes and microspheres
JP2005519873A (ja) * 2001-11-14 2005-07-07 アルザ・コーポレーション カテーテル注入可能なデポー組成物およびそれらの使用
CA2466632C (en) * 2001-11-14 2014-02-11 Alza Corporation Injectable depot compositions and uses thereof
US20070196415A1 (en) * 2002-11-14 2007-08-23 Guohua Chen Depot compositions with multiple drug release rate controls and uses thereof
US20040001889A1 (en) * 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
EP2030611A1 (en) * 2002-07-31 2009-03-04 Alza Corporation Injectable multimodal polymer depot compositions and uses thereof
IL166418A0 (en) * 2002-07-31 2006-01-15 Alza Corp Injectable depot compositions and uses thereof
US20060142234A1 (en) * 2004-12-23 2006-06-29 Guohua Chen Injectable non-aqueous suspension
CN105764491A (zh) 2013-12-09 2016-07-13 度瑞公司 药物活性剂复合物、聚合物复合物，以及包括其的组合物和方法
KR20220140711A (ko) 2020-01-13 2022-10-18 듀렉트 코퍼레이션 불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법
EP4277702A1 (en) 2021-01-12 2023-11-22 Durect Corporation Sustained release drug delivery systems and related methods
US12151024B2 (en) 2021-01-22 2024-11-26 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
EP4415713A4 (en) 2021-10-14 2025-08-06 Pacira Pharmaceuticals Inc MULTIVESICULAR LIPOSOME FORMULATIONS OF BUPIVACAINE AND THEIR USES
US12280149B1 (en) 2024-05-20 2025-04-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12251472B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12156940B1 (en) 2024-05-20 2024-12-03 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995010277A1 (en) * 1993-10-13 1995-04-20 Chiroscience Limited Analgesic agent and its use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0151110B1 (en) * 1983-08-01 1989-03-01 Astra Läkemedel Aktiebolag L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same
EP0821588B1 (en) * 1995-04-13 2003-06-18 Darwin Discovery Limited Levobupivacaine and its use as an anaesthetic in pregnant women

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995010277A1 (en) * 1993-10-13 1995-04-20 Chiroscience Limited Analgesic agent and its use
EP0727210A2 (en) * 1993-10-13 1996-08-21 Chiroscience Limited Analgesic agent and its use

Also Published As

Publication number Publication date
PL335563A1 (en) 2000-05-08
DK0981348T3 (da) 2003-09-15
KR100535554B1 (ko) 2005-12-08
US5910502A (en) 1999-06-08
CN1249683A (zh) 2000-04-05
EP0981348B1 (en) 2003-05-21
CA2279498C (en) 2009-05-26
AU719483B2 (en) 2000-05-11
NO994259D0 (no) 1999-09-02
HU224227B1 (hu) 2005-06-28
HUP0000963A3 (en) 2000-10-30
AU6631098A (en) 1998-09-22
DE69814852T2 (de) 2004-01-22
PL190896B1 (pl) 2006-02-28
BR9808302A (pt) 2000-05-16
JP2001513814A (ja) 2001-09-04
WO1998038999A1 (en) 1998-09-11
EP0981348A1 (en) 2000-03-01
GB9704351D0 (en) 1997-04-23
PT981348E (pt) 2003-09-30
DE69814852D1 (de) 2003-06-26
ZA981780B (en) 1999-03-03
CA2279498A1 (en) 1998-09-11
HUP0000963A2 (hu) 2000-09-28
HK1022649A1 (en) 2000-08-18
NO994259L (no) 1999-11-02
ATE240731T1 (de) 2003-06-15
ES2199424T3 (es) 2004-02-16
KR20000075894A (ko) 2000-12-26
NO324215B1 (no) 2007-09-10
IL131086A0 (en) 2001-01-28

Similar Documents

Publication Publication Date Title
CN1107504C (zh) 左布比卡因在儿科手术中的用途
Karalliedde et al. Acute organophosphorus insecticide poisoning in Sri Lanka
de Boer et al. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study
KR100343314B1 (ko) 만성통증치료에유용한레보부피바카인
Smith et al. Efficacy of esmolol versus alfentanil as a supplement to propofol-nitrous oxide anesthesia
Wadon et al. Atracurium infusion in the intensive care unit
Chan-Yeung The effect of Sch 1000 and disodium cromoglycate on exercise-induced asthma
Whelan Baclofen in treatment of the'stiff-man'syndrome
Powles et al. Use of vecuronium in the management of tetanus
RU2152215C1 (ru) Применение ропивакаина при изготовлении фармацевтического препарата с анальгезирующим действием с минимальной моторной блокадой
Zahedi Comparison of tramadol and pethidine for postanesthetic shivering in elective cataract surgery
Adu-Gyamfi Epidural morphine plus bupivacaine for relief of postoperative pain following Harrington rod insertion for correction of idiopathic scoliosis
MXPA99008057A (en) The use of levobupivacaine in paediatric surgery
Broadman et al. Caudal blocks
HK1022649B (en) The use of levobupivacaine in paediatric surgery
Leoni et al. Pain control with low-dose alfentanil in children undergoing minor abdominal and genito-urinary surgery
Hara Darvon poisoning: case report of a three year old Negro male and review of the literature
Cameron et al. Which beta blocker?
Jackson creased respiratory resistance provoked by ultrasonic aerosols
Grebb et al. A pilot study of the efficacy and safety of A-81418 in reducing symptoms of nicotine withdrawal
Berry et al. On Use of Priming With Vecuronium in a Patient With an Open Globe and a Full Stomach
Yentis Supraventricular tachycardia (SVT) during caesarean section
Kempen Succinylcholine in Children
Kaye New drugs: beta blockers and sympathomimetics
SOMNER et al. J H ANGEL

Legal Events

Date Code Title Description
C06 Publication
C10 Entry into substantive examination
PB01 Publication
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CX01 Expiry of patent term

Granted publication date: 20030507

CX01 Expiry of patent term